Cystic fibrosis (CF): Utilizing Personalized Treatments and Addressing Health Disparities Course
hosted byOptumHealth Education (OHE)Cystic fibrosis (CF): Utilizing Personalized Treatments and Addressing Health Disparities Course is organized by OptumHealth Education (OHE).
Activity opens: 05/25/2021
Activity expires: 06/01/2024
Target Audience:
This activity is designed to meet the educational needs of case managers, counselors, nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists, social workers, therapists and other HCPs who treat individuals with CF.
Description:
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Guidelines are available to assist health care professionals (HCPs) and caregivers in evaluating and monitoring individuals, detecting complications and preventing clinical deterioration. Despite this, disparities are found in the management and outcome of individuals with CF. It is plausible that these disparities in disease outcome result from delayed diagnosis, lack of specialized care and limited access to medications. In CF, there are multiple gravity phenotypes and clinical manifestations that are described and come from complex interactions between mutations in the CFTR gene, modifier genes, environment and lifestyle. Thus, personalized medicine is essential in CF management.
During this activity, presenters will discuss CF and the different genetic etiologies and examine how an individual’s genetic profile can be utilized to develop a personalized treatment plan. The role that an informed interprofessional health care team can play in improved disease outcomes will also be examined.
Learning Objectives:
At the end of this educational activity, participants should be able to:
• Describe CF and its different genetic etiologies.
• Explain how an individual’s genetic profile can be utilized to develop a personalized CF treatment plan.
• Discuss the prevalence of CF in different racial and ethnic groups.
• Address health disparities among individuals with CF related to their socioeconomic status, residential geographic location and access to genetic evaluations and CF centers.
• Recognize other environmental factors that impact outcomes for individuals with CF.